Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cooperative disease management programs.

C M Jedrey1, K A Chaurette, L B Winn

  • 1McDermott, Will & Emery, Boston, Massachusetts, USA.

The Journal of Ambulatory Care Management
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Special labeling requirements for genetically engineered food: how sound are the analytical frameworks used by FDA and food producers?

Food and drug law journal·2002
Same author

Transmission/disequilibrium test analysis of total serum IgE levels in the Hutterite and Collaborative Study on the Genetics of Asthma data sets.

Genetic epidemiology·2002
Same author

Comparison of three methods for obtaining principal components from family data in genetic analysis of complex disease.

Genetic epidemiology·2002
Same author

Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2.

American journal of human genetics·2000
Same journal

Improving Rates of Cardiac Stress Test Completion through Scheduling Interventions.

The Journal of ambulatory care management·2026
Same journal

The Association Between Federally Qualified Health Centers' Payer Mix and Clinical Outcomes Pre- and Post-COVID-19.

The Journal of ambulatory care management·2026
Same journal

"To Get the Patient the Best Care": A Qualitative Analysis of Community Health Worker Integration in North Carolina Federally Qualified Health Centers.

The Journal of ambulatory care management·2026
Same journal

From the Editors: From Operations to Social Needs: Advancing Ambulatory Care Practice.

The Journal of ambulatory care management·2026
Same journal

Enhancing Access in Academic Medical Centers Through Incentive-Based Evening and Weekend Clinics.

The Journal of ambulatory care management·2026
Same journal

Characterizing Energy Insecurity: Utility Shut-Off Protection Requests in Pediatric Primary Care.

The Journal of ambulatory care management·2026
See all related articles

Pharmaceutical company partnerships in disease management offer patient benefits when structured compliantly. These programs must prioritize patient well-being over product promotion to adhere to regulations.

Area of Science:

  • Health Services Research
  • Pharmaceutical Policy
  • Patient Advocacy

Background:

  • Cooperative disease management programs are increasingly utilized in healthcare.
  • Pharmaceutical sponsorships present opportunities and challenges for patient care.
  • Regulatory compliance is crucial for healthcare program integrity.

Purpose of the Study:

  • To evaluate the benefits of cooperative disease management programs.
  • To examine the regulatory framework governing such programs.
  • To define conditions for compliant pharmaceutical sponsorship.

Main Methods:

  • Analysis of existing cooperative disease management program structures.
  • Review of Office of Inspector General (OIG), FDA, and IRS regulations.

Related Experiment Videos

  • Assessment of program designs for patient-centricity and compliance.

    • Main Results:

    • Programs can yield significant patient benefits when properly designed.
    • Compliance with OIG, FDA, and IRS regulations is achievable.
    • Key is structuring programs for patient welfare, not product promotion.

    Conclusions:

    • Pharmaceutical-sponsored disease management programs can be beneficial and compliant.
    • Patient-centric design is paramount for ethical and legal program operation.
    • Careful structuring ensures programs serve patients effectively without undue influence.